Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00061984 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

455

Enrollment

NETWORK

Sponsor class

Conditions

Sarcoma

Interventions

BIOLOGICAL: pegfilgrastim
DRUG: doxorubicin hydrochloride
DRUG: ifosfamide
PROCEDURE: multimodality therapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC